Delivery Order SPE2DB20D2104-SPE2DB25FMVAL
- Not listed
- The Defense Logistics Agency awarded a $1,243.00 delivery order to AmerisourceBergen Drug Corp for VERQUVO 10 mg tablets (30-count units) on April 22, 2025, with completion scheduled for April 23, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical products will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Verquvo 10 mg tablets (quantity 90) at a firm fixed price of $12,569.21, with completion targeted for September 3, 2025. This contract represents a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,669.85 to AmerisourceBergen Drug Corp for the supply of Verquvo 10 mg tablets (30-count packaging) on June 13, 2025, with completion scheduled for June 16, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Verquvo 5 mg tablets (14-count units) with a ceiling value of $7,605.92 under a firm fixed price contract. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VERQUVO 10 mg tablets (30-count units) valued at $2,749.50 under a firm fixed-price contract type. The award was made on June 16, 2025, with an ultimate completion date of June 17, 2025. This delivery order is not set-aside and was competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. AmerisourceBergen Drug Corp serves as a critical vendor within the federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Verquvo 5 mg tablets in quantities of 30 units, with a contract ceiling value of $1,006.41. This firm fixed-price delivery order, which has an ultimate completion date of November 12, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order valued at $2,310.12 to AmerisourceBergen Drug Corp for VERQUVO 5 MG tablets (100-count unit dose packaging) with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order, awarded on July 23, 2025, represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $2,415.96 to AmerisourceBergen Drug Corp for Verquvo 5 mg tablets (14-count packaging) on September 12, 2025, with completion scheduled for September 15, 2025. This firm fixed-price delivery order is unclassified and carries no set-aside designation, indicating competitive award status. The award leverages AmerisourceBergen's position as a major pharmaceutical distributor and represents a child order under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,310.12 to AmerisourceBergen Drug Corp for VERQUVO 5 mg tablets (100-unit dose packages) with a completion date of September 2, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and a key...
- The Defense Logistics Agency awarded a $7,091.65 delivery order to AmerisourceBergen Drug Corp for VERQUVO 5 mg tablets (14-count packaging) on November 3, 2025, with completion targeted for November 4, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMVALDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,227.26 to AmerisourceBergen Drug Corp for the supply of Verquvo 10 mg tablets (30-count packaging). The award, made on July 8, 2025, with an ultimate completion date of July 9, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The firm fixed-price structure and rapid fulfillment timeline of this delivery order exemplify the operational flexibility of the underlying IDC, which encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 7/8/25 |